234 related articles for article (PubMed ID: 31565986)
1. Evaluating the Clinical Outcomes of Parotid Hemangiomas in the Pediatric Patient Population.
Harris J; Phillips JD
Ear Nose Throat J; 2021 Jun; 100(5):NP242-NP245. PubMed ID: 31565986
[TBL] [Abstract][Full Text] [Related]
2. Oral propranolol therapy in parotid hemangiomas: A retrospective comparison with other infantile hemangiomas.
Wang L; Li S; Gao Q; Lv R; Xu G; Li X; Bi J; Huo R
Head Neck; 2021 May; 43(5):1553-1562. PubMed ID: 33539620
[TBL] [Abstract][Full Text] [Related]
3. Oral propranolol for parotid infantile hemangiomas.
Li G; Xu DP; Sun HL; Cheng C; Liu ZM; Xi SL; Wang XK
J Craniofac Surg; 2015 Mar; 26(2):438-40. PubMed ID: 25692890
[TBL] [Abstract][Full Text] [Related]
4. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
[TBL] [Abstract][Full Text] [Related]
5. Use of propranolol for parotid hemangioma.
Chang L; Jin Y; Lv D; Ying H; Wang T; Qiu Y; Ma G; Chen H; Yu W; Yang X; Lin X
Head Neck; 2016 Apr; 38 Suppl 1():E1730-6. PubMed ID: 26676449
[TBL] [Abstract][Full Text] [Related]
6. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas.
Moyakine AV; Herwegen B; van der Vleuten CJM
J Am Acad Dermatol; 2017 Nov; 77(5):868-873. PubMed ID: 28818436
[TBL] [Abstract][Full Text] [Related]
7. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
8. Propranolol in the Treatment of Infantile Hemangiomas: A Meta-Analysis in Chinese Patients.
Li LL; Yan L; Luo MX; Cai YX; Mi XB; Zhang TD
Pediatr Dermatol; 2015; 32(5):e210-4. PubMed ID: 26060892
[TBL] [Abstract][Full Text] [Related]
9. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
[TBL] [Abstract][Full Text] [Related]
10. Management of infantile hemangiomas-experience of a tertiary hospital.
Gomes R; Salazar L; Fraga C; Correia MR; Barbosa-Sequeira J; Fernandes A; Álvares S; Banquart Leitão J; Paiva Coelho M
Eur J Pediatr; 2023 Apr; 182(4):1611-1618. PubMed ID: 36705724
[TBL] [Abstract][Full Text] [Related]
11. Predictors of poor response to oral propranolol in infantile hemangiomas.
Hali F; Moubine I; Berrami H; Serhier Z; Othmani MB; Chiheb S
Arch Pediatr; 2023 Oct; 30(7):455-457. PubMed ID: 37394367
[TBL] [Abstract][Full Text] [Related]
12. [Intralesional Pingyangmycin therapy for 51 infantile patients with parotid gland hemangiomas].
Wang LL; Gao QH; Liu K; Wang XY; Wang CM; Wen YM
Shanghai Kou Qiang Yi Xue; 2009 Apr; 18(2):142-6. PubMed ID: 19417988
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study.
Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S
J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
15. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.
Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J
Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants.
de Graaf M; Breur JMPJ; Raphaël MF; Vos M; Breugem CC; Pasmans SGMA
J Am Acad Dermatol; 2011 Aug; 65(2):320-327. PubMed ID: 21601311
[TBL] [Abstract][Full Text] [Related]
17. Does Oral Propranolol Improve the Final Outcome of All Involuted Infantile Hemangiomas? A Matched Retrospective Comparative Study.
Chang SJ; Chang HF; Qiu Y; Chang L; Jin Y; Lin X
Ann Plast Surg; 2022 Aug; 89(2):214-217. PubMed ID: 35502973
[TBL] [Abstract][Full Text] [Related]
18. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
20. Management of parotid hemangioma in 100 children.
Greene AK; Rogers GF; Mulliken JB
Plast Reconstr Surg; 2004 Jan; 113(1):53-60. PubMed ID: 14707622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
